News
Brexit and illegal drug use monitoring: five minutes with . . . Alexis Goosdeel
BMJ 2019; 365 doi: https://doi.org/10.1136/bmj.l4306 (Published 20 June 2019) Cite this as: BMJ 2019;365:l4306
- Rory Watson
- Brussels
“If there is no agreement [on Brexit], there would no longer be any cooperation between the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and the UK. In practical terms, this means the UK would not be part of the EU’s early warning system on new psychoactive substances. As …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.